Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Chanexa Medico AB
AB
Active
Org 5569175192
Sollentuna
Physiotherapy activities
·
NACE 8695
Est. 2013 · 13 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Physiotherapy activities
/
Chanexa Medico AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 2M (+100% vs 2024)
2M
+100%
2025
EBITDA
SEK millions
0M
0M
-1M
-1M
-1M
2021: 0M
0M
2021
2022: -1M
-1M
2022
2023: -1M (0% vs 2022)
-1M
0%
2023
2024: 0M (+100% vs 2023)
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 835
1 062
714
1 078
166
Staff expenses
−1 218
−1 363
−1 330
−1 679
—
EBITDA
450
−470
−737
−840
−393
Depreciation & amort.
—
—
—
—
−0
EBIT
450
−470
−737
−840
−393
Net financials
3
1 030
1 710
808
19
Profit before tax
450
593
718
17
109
Tax
−104
−139
−161
−13
−39
Net profit
346
454
557
4
70
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
2 753
2 619
2 896
2 377
2 244
Equity
1 448
1 528
1 449
1 382
1 565
Long-term debt
—
—
—
—
0
Short-term debt
478
266
589
392
26
Total debt
478
266
589
392
26
Financial ratios
5-year trend
EBITDA margin
24,5 %
This company
15,8 %
Market median
This company
Market median
55% above market
2021
2025
Equity ratio
52,6 %
This company
38,2 %
Market median
This company
Market median
38% above market
2021
2025
Return on equity
23,9 %
This company
18,4 %
Market median
This company
Market median
30% above market
2021
2025
Net profit margin
18,9 %
This company
8,1 %
Market median
This company
Market median
133% above market
2021
2025
Asset turnover
0,67×
This company
1,12×
Market median
This company
Market median
40% below market
2021
2025
Debt / equity
0,90×
This company
0,62×
Market median
This company
Market median
45% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Chanexa Medico AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot